Frank T.

Frank T. has extensive experience in digital biomarker and AI platform development, currently serving as Vice President at Abbott since 2017, where responsibilities include defining the enterprise AI strategy for clinical research and overseeing engineering and data science teams. Prior to Abbott, Frank T. held multiple roles at Illumina from 2000 to 2016, including Staff Scientist in Clinical Bioinformatics, where Frank led computational workflows for regulated sequencing pipelines and supported oncology and rare disease test development. Frank T. holds a Master of Science in Biomedical/Medical Engineering from UCLA.